Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |